These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17410678)

  • 1. Regulatory beneficiaries and informal agency policymaking.
    Mendelson NA
    Cornell Law Rev; 2007 Mar; 92(3):397-452. PubMed ID: 17410678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Executive Order 13,422, OMB's good guidance practices, and implications for health rulemaking and guidance.
    Harris MD
    J Health Life Sci Law; 2007; 1(1):127, 129-50. PubMed ID: 18610733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Informal guidance and the FDA.
    Lewis KM
    Food Drug Law J; 2011; 66(4):507-50, i. PubMed ID: 24505827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perception and process at the Food and Drug Administration: obligations and trade-offs in rules and guidances.
    Seiguer E; Smith JJ
    Food Drug Law J; 2005; 60(1):17-32. PubMed ID: 15940852
    [No Abstract]   [Full Text] [Related]  

  • 5. Naturally occurring asbestos: a recurring public policy challenge.
    Lee RJ; Strohmeier BR; Bunker KL; Van Orden DR
    J Hazard Mater; 2008 May; 153(1-2):1-21. PubMed ID: 18180100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit adequacy among elderly Social Security retired-worker beneficiaries and the SSI federal benefit rate.
    Rupp K; Strand A; Davies P; Sears J
    Soc Secur Bull; 2007; 67(3):29-51. PubMed ID: 18605217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administrative practices and procedures; promulgation of regulations for the efficient enforcement of law--FDA. Final rule.
    Fed Regist; 1991 Apr; 56(65):13757-8. PubMed ID: 10111150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Food after Fukushima--Japan's regulatory response to the radioactive contamination of its food chain.
    Berends G; Kobayashi M
    Food Drug Law J; 2012; 67(1):51-64, i-ii. PubMed ID: 24624648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug interaction studies: study design, data analysis, and implications for dosing and labeling.
    Huang SM; Temple R; Throckmorton DC; Lesko LJ
    Clin Pharmacol Ther; 2007 Feb; 81(2):298-304. PubMed ID: 17259955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Year 2000 (Y2K) computer compliance guide; guidance for FDA personnel. Food and Drug Administration. Notice.
    Fed Regist; 1999 May; 64(93):26424-6. PubMed ID: 10558534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disabled workers and the indexing of Social Security benefits.
    Strand A; Rupp K
    Soc Secur Bull; 2007; 67(4):21-50. PubMed ID: 18777668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical marketing practices: balancing public health and law enforcement interests; moving beyond regulation-through-litigation.
    Zalesky CD
    J Health Law; 2006; 39(2):235-64. PubMed ID: 17002233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA-EPA Public Health Guidance on Fish Consumption: A Case Study on Informal Interagency Cooperation in "Shared Regulatory Space".
    Holden M
    Food Drug Law J; 2015; 70(1):101-42, i. PubMed ID: 26292474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acquisition and utilization of technical information by administrative agencies.
    Sabatier P
    Adm Sci Q; 1978 Sep; 23(3):396-417. PubMed ID: 10297211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioanalytical method validation: notable points in the 2009 draft EMA Guideline and differences with the 2001 FDA Guidance.
    Smith G
    Bioanalysis; 2010 May; 2(5):929-35. PubMed ID: 21083222
    [No Abstract]   [Full Text] [Related]  

  • 16. Science policy. New regulatory czar takes charge.
    Kaiser J
    Science; 2001 Oct; 294(5540):32-3. PubMed ID: 11588229
    [No Abstract]   [Full Text] [Related]  

  • 17. Strengthening the regulation of clinical trials and bioresearch monitoring.
    FDA Consum; 2006; 40(6):35. PubMed ID: 17333566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reforming state-level chemicals management policies in the United States: status, challenges, and opportunities.
    Geiser K; Tickner J; Torrie Y
    New Solut; 2009; 19(1):9-29. PubMed ID: 19447756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical use of byproduct material; public meetings--NRC. Notice of public meetings.
    Fed Regist; 1998 Jul; 63(142):39763-5. PubMed ID: 10181515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.